Join to access to all OVN content. Join for Free
The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges
MSL trends skills for MSLs digital literacy in healthcare future-proof MSL career patient-centric MSLs

The Future of MSL Roles: Skills and Competencies for Tomorrow’s Challenges


Share This Article


Summary

This week’s guest is Stephanie Otis, Vice President Global Medical Excellence at Ferring Pharmaceuticals discusses future trends in the MSL field including the skills and competencies that will be essential for success.

Key Points

  • Scientific acumen, storytelling, and relationship-building remain the fundamental core competencies for successful MSLs, even as the role evolves with new technologies and business acumen.
  • MSLs must develop technical skills and digital literacy to adapt to rapidly changing healthcare landscapes, incorporating emerging technologies like AI and machine learning.
  • Future-proofing an MSL career involves maintaining learning agility and demonstrating enterprise leadership while ensuring patient-centricity in every aspect of their work.

Click for Source
MSL trends, skills for MSLs, digital literacy in healthcare, future-proof MSL career, patient-centric MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Layoff Ready... How to Plan and Prepare for Potential Career Transition
Partner Avatar MSL Talk: Tom Caravela, Chad Schroer

Layoff Ready... How to Plan and Prepare for Potential Career Transition

Podcast
How to create HIGH performing MSLs, teams and MSL leaders
Partner Avatar MSL Talk: Tom Caravela, Mike Penkethman

How to create HIGH performing MSLs, teams and MSL leaders

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN